Drug intelligence / Profile preview

EPINORM

Development stage
Unknown
Lead developer
Epitech
Modality
Small Molecules
Administration
Topical, Vaginal
01

Overview

EPINORM is a topical gel formulation developed by Epitech, primarily containing the ALIAmide adelmidrol. It is designed for gynecological applications, specifically to manage chronic pelvic pain, vulvar discomfort, and to promote healing after episiotomy. The mechanism of action involves the ALIA (Autacoid Local Injury Antagonism) effect, where adelmidrol modulates the activation and degranulation of mast cells and other non-neuronal immune cells. By downregulating mast cell hyperactivity, EPINORM helps reduce inflammation and associated pain in the pelvic and vaginal tissues. It is currently approved and marketed in certain regions, particularly in Europe, often classified as a medical device for local application.

Brand names
EPINORMEPINORM GEL
Other names
Adelmidrol gel
02

Targets

PPARG (Peroxisome proliferator-activated receptor gamma)

Beyond the preview

Go deeper on EPINORM.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on EPINORM.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call